Real-World Evidence BRIDGE: A Tool to Connect Protocol With Code Programming

被引:0
|
作者
Royo, Albert Cid [1 ]
Elbers, J. H. J. Roel [1 ]
Weibel, Daniel [1 ]
Hoxhaj, Vjola [1 ]
Kurkcuoglu, Zeynep [1 ]
Sturkenboom, Miriam C. J. [1 ]
Vaz, Tiago A. [1 ]
Navarro, Constanza L. Andaur [1 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Data Sci & Biostat, Utrecht, Netherlands
关键词
drug safety; drug utilization; electronic health records; pharmacoepidemiology; vaccines;
D O I
10.1002/pds.70062
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
ObjectiveTo enhance documentation on programming decisions in Real World Evidence (RWE) studies.Materials and MethodsWe analyzed several statistical analysis plans (SAP) within the Vaccine Monitoring Collaboration for Europe (VAC4EU) to identify study design sections and specifications for programming RWE studies. We designed a machine-readable metadata schema containing study sections, codelists, and time anchoring definitions specified in the SAPs with adaptability and user-friendliness.ResultsWe developed the RWE-BRIDGE, a metadata schema in form of relational database divided into four study design sections with 12 tables: Study Variable Definition (two tables), Cohort Definition (two tables), Post-Exposure Outcome Analysis (one table), and Data Retrieval (seven tables). We provide a guide to populate this metadata schema and a Shiny app that checks the tables. RWE-BRIDGE is available on GitHub ().DiscussionThe RWE-BRIDGE has been designed to support the translation of study design sections from statistical analysis plans into analytical pipelines and to adhere to the FAIR principles, facilitating collaboration and transparency between researcher and programmers. This metadata schema strategy is flexible as it can support different common data models and programming languages, and it is adaptable to the specific needs of each SAP by adding further tables or fields, if necessary. Modified versions of the RWE-BRIGE have been applied in several RWE studies within VAC4EU.ConclusionRWE-BRIDGE offers a systematic approach to detailing variables, time anchoring, and algorithms for RWE studies. This metadata schema facilitates communication between researcher and programmers.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] An FDA quality assessment tool for evaluation of real-world evidence observational studies
    Bradley, Marie C.
    Hua, Wei
    Pinheiro, Simone
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 418 - 418
  • [32] Impact of the introduction of a standardised ICD programming protocol: real-world data from a single centre
    Nicholas Sunderland
    Amit Kaura
    Anthony Li
    Ravi Kamdar
    Ed Petzer
    Para Dhillon
    Francis Murgatroyd
    Paul A. Scott
    Journal of Interventional Cardiac Electrophysiology, 2016, 46 : 335 - 343
  • [33] IMPACT OF THE INTRODUCTION OF A STANDARDISED ICD PROGRAMMING PROTOCOL: REAL-WORLD DATA FROM A SINGLE CENTRE
    Sunderland, Nicholas
    Kaura, Amit
    Li, Anthony
    Kamdar, Ravi
    Petzer, Ed
    Dhillon, Para
    Murgatroyd, Francis
    Scott, Paul
    HEART, 2016, 102 : A37 - A37
  • [34] Impact of the introduction of a standardised ICD programming protocol: real-world data from a single centre
    Sunderland, Nicholas
    Kaura, Amit
    Li, Anthony
    Kamdar, Ravi
    Petzer, Ed
    Dhillon, Para
    Murgatroyd, Francis
    Scott, Paul A.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 46 (03) : 335 - 343
  • [35] Real-World Performance of the Guardian Connect System with Sugar.IQ
    Arunachalam, Siddharth
    Zhong, Yuxiang
    Abraham, Sinu Bessy
    Agrawal, Pratik
    Vigersky, Robert
    Cordero, Toni L.
    Kaufman, Francine R.
    DIABETES, 2019, 68
  • [36] Real-World VANET Security Protocol Performance
    Haas, Jason J.
    Hu, Yih-Chun
    Laberteaux, Kenneth P.
    GLOBECOM 2009 - 2009 IEEE GLOBAL TELECOMMUNICATIONS CONFERENCE, VOLS 1-8, 2009, : 2629 - +
  • [37] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [38] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
  • [39] Titration: Where is the real-world evidence?
    Caffrey, Aisling R.
    Borrelli, Eric P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 203 - 204
  • [40] Automating access to real-world evidence
    Gauthier, M-P.
    Law, J. H.
    Le, L.
    Zahir, S.
    Li, J.
    Sung, M.
    Chu, R.
    Leighl, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S879 - S880